The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.
So what role do antibiotics and corticosteroids play in achieving these goals?
Here to address that question is Raymond Cross, MD, Associate Professor of Medicine in the Division of Gastroenterology and Hepatology and Director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine. Dr Cross recently addressed the use of antibiotics and corticosteroids in optimizing therapy at the 2012 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference in Florida.
|Antibiotics and Corticosteroids in IBD|
Antibiotics and Corticosteroids in IBD
Dr Moss is Assistant Professor of Medicine at Harvard Medical School and is a gastroenterologist at Beth Israel Deaconess Medical Center in Boston, Massachusetts. He discussed diagnosis and management of extraintestinal manifestations of IBD in his presentation at the 2012 Advances in Inflammatory Bowel Diseases, the Crohn’s & Colitis Foundation’s Clinical & Research Conference, held December 13-15 in Hollywood, Florida.